Malignant Neoplasms of the Parathyroid Gland


Parathyroid Carcinoma

Parathyroid carcinoma is a malignant neoplasm arising from the parathyroid parenchymal cells, comprising approximately 1% of all primary hyperparathyroidism (HPT) cases (no malignant adipose tumors are recognized in the parathyroid). Secondary parathyroid hyperplasia and neck irradiation are suggested as etiologic factors. There is also an increased incidence of carcinoma in patients with hereditary hyperparathyroidism–jaw tumor (HPT-JT) syndrome. There are no well-accepted histologic features that are used alone to diagnose carcinoma, but a constellation of features can help to confirm the diagnosis.

Clinical Features

Parathyroid Carcinoma—Disease Fact Sheet

Definition

  • A malignant neoplasm derived from parathyroid parenchymal cells

Incidence and Location

  • Accounts for < 2% of primary hyperparathyroidism

  • Slightly higher frequency in lower parathyroid glands

Morbidity and Mortality

  • Adverse effects of hypercalcemia on the cardiovascular system

  • Indolent tumor with recurrences and metastases, up to 15% mortality at 5 years

Sex, Race, and Age Distribution

  • Equal sex distribution

  • Japanese and Italian patients have a higher incidence

  • Wide age range, although predominantly older patients; still ~10 years younger than patients with adenoma

Clinical Features

  • Symptoms referable to excess calcium and parathyroid hormone

  • Nephrolithiasis and bone “brown tumors”

  • Palpable neck mass, often difficult to remove surgically

  • Hoarseness is common with recurrent laryngeal nerve involvement

  • May be part of hereditary hyperparathyroidism–jaw tumor syndrome

  • High serum calcium and parathyroid hormone levels

Prognosis and Therapy

  • Indolent with recurrences common (~50%)

  • Approximately 50% 10-year survival

  • Surgery

Parathyroid carcinoma affects fewer than 1/1,000,000 population per year, develops in all ages, although more frequently in older adults (mean 6th decade) and up to a decade earlier than adenoma. There is no sex bias, distinctly different from the marked female predominance in patients with parathyroid adenoma. Japanese and Italian patients show a higher incidence of carcinoma than other races.

The clinical features are due primarily to the effects of excessive parathyroid hormone (PTH) secretion and hypercalcemia. Laboratory values of greater than 1,000 ng/L for PTH and greater than 16 mg/dL for serum calcium are very concerning for parathyroid carcinoma. The nonspecific symptoms (weakness, fatigue, anorexia, weight loss, nausea, polyuria, polydipsia) overlap with adenoma, but excessively high serum calcium levels (>16 mg/dL) are associated with nephrolithiasis, renal insufficiency, and bone “brown tumors.” Concurrent bone disease and kidney stones are more common in patients with carcinoma than adenoma. A palpable neck mass (in up to 75% of patients) suggests carcinoma and is often difficult to remove at surgery due to adherence to the soft tissues, nerves (recurrent laryngeal nerve involvement gives hoarseness), and/or thyroid gland. Carcinoma may develop in any parathyroid gland but is slightly more common in the lower parathyroid glands.

Most cases are sporadic, with only a small subset associated with familial disease forms. There are recurrent losses of chromosome 13q, the same region known to contain the retinoblastoma (RB1) and BRCA2 tumor suppressor genes. A genomic region frequently lost in parathyroid adenomas is 11q, the location of MEN1 , but it is almost never identified in carcinoma, supporting the contention that parathyroid carcinomas arise de novo rather than from preexisting adenomas. Carcinoma is a component of HPT-JT syndrome, where it is identified in approximately 15% of patients. Carcinomas are rarely associated with prior irradiation, renal failure, and celiac disease. Radiographic studies are usually unreliable in separating adenoma from carcinoma but can aid in planning surgery.

Pathologic Features

Parathyroid Carcinoma—Pathologic Features

Gross Findings

  • Large tumors (mean, 3 cm)

  • Adherent to soft tissues and thyroid gland

  • Firm, gray-white cut surface

  • Central necrosis may be present

Microscopic Findings

  • Adherence to the thyroid gland

  • Capsular, vascular, or perineural invasion

  • Soft tissue extension

  • Tumor cell necrosis (comedonecrosis)

  • Trabecular growth with thick, acellular bands of fibrosis

  • Tumor cell monotony, although profound pleomorphism can be seen

  • High nuclear to cytoplasmic ratio

  • Spindling of tumor cells

  • Prominent, eosinophilic, irregular macronucleoli

  • Increased mitotic figures, including atypical forms

Immunohistochemical Findings

  • Chromogranin and parathyroid hormone, along with keratins

  • Loss of parafibromin

  • Increased Ki-67 labeling index

  • Cyclin D1 overexpression

  • Negative TTF1 and thyroglobulin

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here